WebApr 13, 2024 · RedHill Biopharma (NASDAQ:RDHL) has a market capitalization of $7.73 million and generates $85.76 million in revenue each year. The biotechnology company … WebThe latest price target for . Redhill Biopharma (NASDAQ: RDHL) was reported by HC Wainwright & Co. on September 15, 2024.The analyst firm set a price target for $21.00 expecting RDHL to rise to ...
RedHill Biopharma Ltd. (RDHL) Stock Price, News, Quote ... - Yahoo!
WebApr 14, 2024 · RedHill Biopharma NasdaqGM:RDHL Stock Report Last Price US$3.26 Market Cap US$7.4m 7D -26.6% 1Y -96.7% Updated 06 Apr, 2024 Data Company Financials + 1 Analyst RDHL Stock Overview RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. About the … WebAug 26, 2024 · • Redhill Biopharma RDHL is likely to report quarterly loss at $0.12 per share on revenue of $25. ... • HP HPQ is estimated to report quarterly earnings at $0.84 per share on revenue of $15.91 ... ray dalio hedge fund strategy
Redhill Biopharma Earnings & Revenue 2013-2024: (NASDAQ: …
WebJan 24, 2024 · RedHill Biopharma (RDHL) Analysts Prediction, Stock Forecast & Price Targets - Simply Wall St View Valuation RedHill Biopharma Future Growth Future criteria checks 0/6 We currently don’t have sufficient analyst coverage to forecast growth and revenue for RedHill Biopharma. Key information 50.8% Earnings growth rate 65.3% EPS … WebApr 11, 2024 · Redhill Biopharma Ltd. Stock Earnings Report Current P/E ratio: -0.102 Price (Feb 17, 2024, EOD): $0.229 (Find current average P/E ratios for all sectors below ) RDHL Upcoming Earnings (Q4 2024) RDHL Analysts Price Targets Currently no data available. About Redhill Biopharma Ltd. WebRedHill Biopharma (RDHL) Earnings Date & Reports 615 Followers Portfolio Earnings Data Report Date Feb 22, 2024 Not Confirmed Period Ending 2024 (Q4) Consensus EPS … ray dalio hedge fund success